AnPac Bio-Medical Science Co Operating Income

As of the most recent data (December 2022), ANPC shows a operating income of $-100M. That compares with $-110M in the prior-year period — up 6.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANPC's operating income is now $-100M (was $-110M) — a 6.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether AnPac Bio-Medical Science Co is outperforming or lagging.

Tracking ANPC's operating income over time shows whether AnPac Bio-Medical Science Co is scaling, shrinking, or reshaping that part of the business. The current reading is $-100M That compares with $-110M in the prior-year period — up 6.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has AnPac Bio-Medical Science Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-100M) with ownership activity and broader fundamentals.

AnPac Bio-Medical Science Co's operating income is $-100M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.